Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China
· Delayed Price · Currency is CNY 11.78
+0.05 (0.43%)
Mar 10, 2026, 3:00 PM CST
SHA:603439 Market Cap
SHA:603439 has a market cap or net worth of 4.77 billion as of March 10, 2026. Its market cap has decreased by -9.44% in one year.
Market Cap
4.77B
Enterprise Value
5.32B
Revenue
1.74B
Ranking
n/a
PE Ratio
29.48
Stock Price
11.78
Market Cap Chart
Since April 28, 2020, SHA:603439's market cap has increased from 4.31B to 4.77B, an increase of 10.64%. That is a compound annual growth rate of 1.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Weixinkang Medicine | 4.72B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.68B |
| Newland Pharmaceutical | 4.86B |
| Jianmin Pharmaceutical Group | 4.90B |
| Yabao Pharmaceutical Group | 4.62B |
| Ningbo Menovo Pharmaceutical | 4.92B |
| Jinling Pharmaceutical Company | 4.62B |
| Jinhe Biotechnology CO., LTD. | 4.62B |